In several EU countries, the corona vaccination with the AstraZeneca vaccine has been discontinued for the time being. The EMA gives the all-clear, but points out possible side effects.
- The EMA has pointed out severe allergic reactions as possible side effects of the AstraZeneca vaccination. (see first report)
- Federal Minister of Health Jens Spahn regrets the vaccination ban in some EU countries. (see first report)
- AstraZeneca has announced a significant cut in vaccine deliveries to the EU – Thuringia must now stop the allocation of vaccination appointments. (see update from March 13, 11:45 a.m.)
Update from March 13, 11:45 a.m .: AstraZeneca has announced another drastic cut in its vaccine shipments to the European Union. The British-Swedish pharmaceutical company announced on Friday evening that it intends to deliver 100 million doses to the EU countries in the first half of this year, 30 million of them in the first quarter. Most recently, AstraZeneca had assumed 220 million cans by the middle of the year.
“Although they worked tirelessly to speed up deliveries, AstraZeneca disappointingly has to announce a cut in planned corona vaccine deliveries to the EU,” the company said in a statement. “Unfortunately, export restrictions will now reduce deliveries in the first quarter, and probably will also in the second quarter,” announced AstraZeneca. The EU had accused both the US and the UK, unlike itself, of not exporting any corona vaccine produced in the countries.
Corona vaccine from AstraZeneca: Thuringia stops granting vaccination appointments due to delivery problems
In Thuringia, the allocation of vaccination appointments has now been stopped due to delivery problems and the start of corona vaccinations for general practitioners has been postponed. Health Minister Heike Werner (Linke) described the announced delivery cut as “absolutely unacceptable”. 31,200 AstraZeneca vaccination doses should be delivered to Thuringia in the next two weeks. According to the Ministry of Health, it will now only be 9,600.
Werner criticized Federal Health Minister Spahn, who asked the federal states in February not to withhold any AstraZeneca vaccination doses because the quantities delivered were safe. “That’s exactly what we did and planned every single dose of the vaccine. Now the announcement from the Federal Ministry of Health is forcing us to stop our appointments and to postpone the involvement of general practitioners, ”explained Werner. “This also means that the last spark of trust in binding commitments has been extinguished. I call on the Federal Minister of Health to intervene immediately. “
AstraZeneca corona vaccine: EMA points out anaphylaxis and hypersensitivity
First report from March 13th: Amsterdam – anaphylaxis and hypersensitivity – these two reactions are to be added to the list of possible side effects of AstraZeneca’s corona vaccine. According to the European Medicines Agency (EMA), the British-Swedish vaccine manufacturer’s vaccine can rarely cause these severe allergic reactions.
There are reports of 41 possible anaphylaxis cases among five million vaccinated people in the UK, the EMA said on Friday. After a careful analysis of the data, the committee responsible for vaccine risk assessment considers a connection between the allergic reaction and the vaccination to be at least in some cases probable, according to the authority based in Amsterdam.
At the same time, however, the EMA pointed out that severe allergic reactions are a known, rare side effect even with vaccinations against other diseases. The package insert for the AstraZeneca vaccine against the coronavirus * already recommends that patients should remain under observation for at least 15 minutes after a vaccination in order to be able to react to possible allergic reactions.
Corona vaccine from AstraZeneca: vaccination freeze in several EU countries
Some states in the EU had already announced that they would stop corona vaccinations * with AstraZeneca’s vaccine for the time being. Denmark announced on Thursday that it would suspend vaccinations with the British-Swedish company’s preparation for 14 days. The reason given by the Danish health administration was reports of severe blood clots after people had been vaccinated with the drug.
There was also a death in Denmark *. At the same time, however, the Danes made it clear that it was not yet possible to determine whether there was a connection between the vaccine and the blood clots. Other countries such as Norway, Iceland and Bulgaria also suspended vaccinations with the AstraZeneca agent. In Austria, due to the death of a nurse and three other illnesses *, the use of a certain batch was suspended as a precaution. Sweden and Poland, however, said they would continue to use the AstraZeneca vaccine.
Corona vaccine from AstraZeneca: Spahn regrets vaccination stop – “benefit far greater than risk”
“I regret that on this basis – as of now Friday morning – some countries in the European Union have suspended vaccination with AstraZeneca,” said Federal Health Minister Jens Spahn (CDU) at a press conference on the current Corona situation in Germany on Friday in Berlin. He referred to an assessment by the EMA, according to which there was no noticeable accumulation of thromboses in connection with the AstraZeneca vaccination. By March 10, 30 cases of “thromboembolic events” had been registered in almost five million people who had been vaccinated with the vaccine. The World Health Organization (WHO) agreed with this assessment, as did the Paul Ehrlich Institute (PEI) responsible for Germany.
“With what we know so far, the benefit is far greater than the risk,” assured Spahn. Lothar Wieler, President of the Robert Koch Institute (RKI) *, stated that so far there has been no evidence “that these events are statistically conspicuous”. Austria’s Federal Chancellor Sebastian Kurz (ÖVP) * also campaigned for confidence in the AstraZeneca vaccine on Friday. “Since there are many people who are concerned, I will also be vaccinated with AstraZeneca to show that I have confidence in the vaccine,” announced Kurz.
Corona vaccine from AstraZeneca: Manufacturer rejects worries about side effects
The British-Swedish pharmaceutical company itself has also rejected concerns about serious side effects of the corona vaccination *. “An analysis of our safety data of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis,” a spokesman assured on Friday. This applies to all ages, genders, countries or batches of the AstraZeneca vaccine. “In fact, these events occur less often among vaccinated people than in the general population,” the spokesman said. (ph / dpa / afp) * Merkur.de is an offer from IPPEN.MEDIA
List of rubric lists: © Ronny Hartmann
#AstraZeneca #vortex #delivery #problems #State #stops #assigning #vaccination #appointments #spark #trust #extinguished